Immix Biopharma
IMMX
IMMX
77 hedge funds and large institutions have $247M invested in Immix Biopharma in 2026 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 28 increasing their positions, 13 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
21.49% less ownership
Funds ownership: 72.62% → 51.12% (-21%)
75% less call options, than puts
Call options by funds: $237K | Put options by funds: $947K
Holders
77
Holding in Top 10
2
Calls
$237K
Puts
$947K
Top Buyers
| 1 | +$6.47M | |
| 2 | +$5.18M | |
| 3 | +$5.1M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$3.05M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$2.57M |
Top Sellers
| 1 | -$7.84M | |
| 2 | -$3.22M | |
| 3 | -$2.48M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$2.36M |
| 5 |
PA
Perceptive Advisors
New York
|
-$1.77M |
